Royalty Pharma plc (RPRX) Stock Ticker
RPRX right now
Market factors today
Unlock the full RPRX picture
About Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
RPRX stock facts
| Ticker symbol | RPRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Market cap | $25.8B |
| CEO | Pablo Legorreta |
| Employees | 100 |
| Headquarters | New York, NY, US |
| IPO date | 2020-06-16 |
| Website | www.royaltypharma.com |
What you can see for RPRX on Tickr
Live RPRX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the RPRX report.
Rankings
FAQ
What is the ticker symbol for Royalty Pharma plc?
The ticker symbol for Royalty Pharma plc is RPRX, listed on the NASDAQ.
What is RPRX?
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and…